Summarize with:
Mumbai: Pharma firm Cipla has launched its generic version of antiviral drug remdesivir without disclosing price but claimed to be at a price which is among the lowest globally and is looking to supply over 80,000 vials within the first month, company said.
Cipla had earlier said the drug will be priced at less than Rs 5,000 per 100 mg vial in line with its overall philosophy of driving access and affordability.
Recently, Hetero Labs Ltd has priced its generic version of remdesivir, Gilead’s experimental COVID-19 drug, at 5,400 rupees per 100-milligram vial.
Summarize with:
